Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension

被引：13
|
作者：
Savale, Laurent [1 ,2 ,3 ]
Chaumais, Marie-Camille [3 ,4 ,5 ]
Montani, David [1 ,2 ,3 ]
Jais, Xavier [1 ,2 ,3 ]
Hezode, Christophe [8 ]
Antonini, Teresa-Maria [1 ,6 ,7 ]
Coilly, Audrey [1 ,6 ,7 ]
Duclos-Vallee, Jean-Charles [1 ,6 ,7 ]
Samuel, Didier [1 ,6 ,7 ]
Simonneau, Gerald [1 ,2 ,3 ]
Humbert, Marc [1 ,2 ,3 ]
Sitbon, Olivier [1 ,2 ,3 ]
机构：
[1] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Serv Pneumol, Dept Hosp Univ DHU Thorax Innovat, F-94270 Le Kremlin Bicetre, France
[3] Hop Marie Lannelongue, INSERM, UMR S 999, Le Plessis Robinson, France
[4] Univ Paris 11, Fac Pharm, Chatenay Malabry, France
[5] Hop Antoine Beclere, DHU Thorax Innovat, Serv Pharm, Clamart, France
[6] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, DHU Hepatinov, Villejuif, France
[7] INSERM, Unite 1193, F-94800 Villejuif, France
[8] Hop Henri Mondor, AP HP, Serv Hepatol, Creteil, France
来源：
CHEST | 2016年 / 150卷 / 01期
关键词：
D O I：
10.1016/j.chest.2016.04.031
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：256 / 258
页数：3
相关论文
共 50 条
  • [1] Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension Response
    Borentain, Patrick
    Renard, Sebastien
    Colson, Philippe
    [J]. CHEST, 2016, 150 (01) : 258 - 258
  • [2] Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
    Kiser, Jennifer J.
    Flexner, Charles
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013, 2013, 53 : 427 - 449
  • [3] Hepatitis C virus infection in children in the era of direct-acting antiviral
    Pawlowska, Malgorzata
    Sobolewska-Pilarczyk, Malgorzata
    Domagalski, Krzysztof
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (24) : 2555 - 2566
  • [4] Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nakamura, Masato
    Jiang, Xia
    Miyamura, Tatsuo
    Wu, Shuang
    Yokosuka, Osamu
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (01) : 1 - 6
  • [5] Hepatitis C Virus Infection and Rheumatic Diseases The Impact of Direct-Acting Antiviral Agents
    Cacoub, Patrice
    Commarmond, Cloe
    Sadoun, David
    Desbois, Anne Claire
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (01) : 123 - +
  • [6] Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?
    Asselah, Tarik
    Marcellin, Patrick
    Schinazi, Raymond F.
    [J]. LIVER INTERNATIONAL, 2018, 38 : 7 - 13
  • [7] Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
    Baumert, Thomas F.
    Berg, Thomas
    Lim, Joseph K.
    Nelson, David R.
    [J]. GASTROENTEROLOGY, 2019, 156 (02) : 431 - 445
  • [8] Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient
    Chute, Donald F.
    Chung, Raymond T.
    Sise, Meghan E.
    [J]. KIDNEY INTERNATIONAL, 2018, 93 (03) : 560 - 567
  • [9] Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection
    Feld, Jordan J.
    Jacobson, Ira M.
    Sulkowski, Mark S.
    Poordad, Fred
    Tatsch, Fernando
    Pawlotsky, Jean-Michel
    [J]. LIVER INTERNATIONAL, 2017, 37 (01) : 5 - 18
  • [10] Direct-acting antiviral treatments in Australia for children with chronic hepatitis C virus infection
    Eldredge, Jessica A.
    Stormon, Michael O.
    Clark, Julia E.
    Nightingale, Scott
    McMullan, Brendan
    Andersen, Brooke
    Travers, Christina
    Hardikar, Winita
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2023, 218 (05) : 229 - 230
12345